December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine

March 29, 2023

TTUHSC El Paso Hunt School of Dental Medicine Receives $10,000 Gift from Trellis Company

TTUHSC El Paso Receives $10K from Trellis

Inside Dentistry

August 09, 2024

Updated Guidance on Contraceptive Use

The CDC has released updated contraceptive guidance for health care providers, emphasizing patient autonomy and evidence-based recommendations to support high-quality, equitable contraceptive care.

Conexiant

April 24, 2023

What Does Dobbs v. Jackson Mean for Oncology Patients and Providers? Current Considerations for Pregnancy and Fertility in the Oncology Setting

The incidence of cancers such as colorectal cancer, head and neck cancer, and melanoma has increased in younger patients. The number of cancer survivors is also increasing in the US. Pairing these fac...

JADPRO

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant

December 02, 2024

ACOG Takes Stance on Self-Managed Abortion

"The greatest risk of harm related to SMA [self-managed abortion] comes from the threat of criminalization."

Conexiant

May 09, 2024

Parental Stress Shows Impact on Child Mental Health

Study reveals striving for 'perfect parenting' increases burnout and mental health issues in children.

Conexiant

February 14, 2024

Updated Guidance on Treatment of Acne

New guidelines from the American Academy of Dermatology provide updated advice on managing acne in patients aged 9 years and older, offering insights into topical, systemic, and physical therapies.

Conexiant

December 02, 2024

2024 Vitamin D Guidelines: A Critical Review

"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."

Conexiant